Literature DB >> 20133016

Association of AICD and Fe65 with Hirano bodies reduces transcriptional activation and initiation of apoptosis.

Sangdeuk Ha1, Ruth Furukawa, Marcus Fechheimer.   

Abstract

Hirano bodies are cytoplasmic inclusions predominantly found in the central nervous system associated with various conditions including aging and Alzheimer's disease (AD). Since most studies of Hirano bodies have been performed in post-mortem samples, the physiological roles of Hirano bodies have not been investigated. Astrocytoma H4 cells were employed to test the hypothesis that Hirano bodies interact with and modulate signaling by the C-terminal fragment of amyloid-β precursor protein (AICD). We demonstrated by immunofluorescence and immunoprecipitation that model Hirano bodies accumulate AICD. Since stimulation of transcription by AICD is dependent on its interaction with the nuclear adaptor protein Fe65, we examined localization of Fe65, and employed a dual luciferase reporter assay to test the effects of Hirano bodies on AICD- and Fe65-dependent modulation of gene expression. We find that both AICD and Fe65 are co-localized in model Hirano bodies. Model Hirano bodies also down-regulate both AICD-dependent apoptosis and AICD- and Fe65-dependent transcriptional activity. Thus, association of AICD and Fe65 with Hirano bodies impedes their function in promoting apoptosis and modulating transcription.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20133016      PMCID: PMC2894277          DOI: 10.1016/j.neurobiolaging.2010.01.003

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  62 in total

1.  Numbers of Hirano bodies in the hippocampus of normal and demented people with Alzheimer's disease.

Authors:  P H Gibson; B E Tomlinson
Journal:  J Neurol Sci       Date:  1977-08       Impact factor: 3.181

2.  Ultrastructure of Hirano bodies.

Authors:  S S Schochet; W F McCormick
Journal:  Acta Neuropathol       Date:  1972       Impact factor: 17.088

3.  A study of rod-like structures (Hirano bodies) in 240 normal and pathological brains.

Authors:  J Ogata; G N Budzilovich; H Cravioto
Journal:  Acta Neuropathol       Date:  1972       Impact factor: 17.088

4.  The association of actin with Hirano bodies.

Authors:  J E Goldman
Journal:  J Neuropathol Exp Neurol       Date:  1983-03       Impact factor: 3.685

5.  Hirano bodies in myelinated fibers of hepatic encephalopathy.

Authors:  K Okamoto; S Hirai; A Hirano
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

6.  Hirano bodies in the perikaryon of the Purkinje cell in a case of Alzheimer's disease.

Authors:  T Yamamoto; A Hirano
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

7.  The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor.

Authors:  Ruth C von Rotz; Bernhard M Kohli; Jérôme Bosset; Michelle Meier; Toshiharu Suzuki; Roger M Nitsch; Uwe Konietzko
Journal:  J Cell Sci       Date:  2004-09-01       Impact factor: 5.285

8.  Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain.

Authors:  Kaushik Ghosal; Daniel L Vogt; Man Liang; Yong Shen; Bruce T Lamb; Sanjay W Pimplikar
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-16       Impact factor: 11.205

Review 9.  Adaptor protein interactions: modulators of amyloid precursor protein metabolism and Alzheimer's disease risk?

Authors:  Gwendalyn D King; R Scott Turner
Journal:  Exp Neurol       Date:  2004-02       Impact factor: 5.330

10.  Dissection of amyloid-beta precursor protein-dependent transcriptional transactivation.

Authors:  Xinwei Cao; Thomas C Südhof
Journal:  J Biol Chem       Date:  2004-03-24       Impact factor: 5.157

View more
  6 in total

Review 1.  Apoptosis in Alzheimer's disease: an understanding of the physiology, pathology and therapeutic avenues.

Authors:  M Obulesu; M Jhansi Lakshmi
Journal:  Neurochem Res       Date:  2014-10-17       Impact factor: 3.996

2.  Model Hirano bodies protect against tau-independent and tau-dependent cell death initiated by the amyloid precursor protein intracellular domain.

Authors:  Matthew Furgerson; Marcus Fechheimer; Ruth Furukawa
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

3.  Transgenic mouse model for the formation of Hirano bodies.

Authors:  Sangdeuk Ha; Ruth Furukawa; Michael Stramiello; John J Wagner; Marcus Fechheimer
Journal:  BMC Neurosci       Date:  2011-10-06       Impact factor: 3.288

4.  Hirano bodies differentially modulate cell death induced by tau and the amyloid precursor protein intracellular domain.

Authors:  William Spears; Matthew Furgerson; John Michael Sweetnam; Parker Evans; Marla Gearing; Marcus Fechheimer; Ruth Furukawa
Journal:  BMC Neurosci       Date:  2014-06-14       Impact factor: 3.288

5.  Hirano body expression impairs spatial working memory in a novel mouse model.

Authors:  Matthew Furgerson; Jason K Clark; Jonathon D Crystal; John J Wagner; Marcus Fechheimer; Ruth Furukawa
Journal:  Acta Neuropathol Commun       Date:  2014-09-02       Impact factor: 7.801

6.  De novo actin polymerization is required for model Hirano body formation in Dictyostelium.

Authors:  Yun Dong; Sonbol Shahid-Salles; Dan Sherling; Nathan Fechheimer; Nathan Iyer; Lance Wells; Marcus Fechheimer; Ruth Furukawa
Journal:  Biol Open       Date:  2016-06-15       Impact factor: 2.422

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.